chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I Gave the Influenza and MMRV Vaccines which had no reaction per mother. Someone else did the DTap/IPV vaccine and mother said pt had long sleeve on but didn't notice reaction till she got home and saw the Right aRm where the injection site was swollen at the site. Per Dr. and Pts mother shot was given too low on the aRm.
After having a rather uneventful first two doses (very minimal side effects), I decided to get my booster shot ~8 months after my two dose series.  Being about two days now from that 3rd dose, I have been experiencing chest pain and shortness of breath. At the time of me writing this it is Christmas so I am unable to go to any sort of doctor or medical facility to get examined. However, I will be getting examined in the following week so long as my symptoms continue to persist.  The Chest pain is quite persistent and I feel it almost directly in the middle of my chest and I wanted to get ahead of the curve and report it to the system. If the symptoms do persist, I will write a follow up report contingent upon my diagnosis.
This case was reported by a healthcare professional and describe the occurrence of injection site redness in a 4-year-old female subject who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included varicella virus vaccine (non-gsk); manufacturer unspecified; unknown given on 17 June 2013. On 17 June 2013 at 14:00 the subject received a dose of KINRIX (.5 ml, unknown route, left thigh) as the 5th dose in the series, and experienced vaccine administered at inappropriate site. KINRIX was administered in the thigh rather than the deltoid as indicated. On 18 June 2013, 24 hours after vaccination with KINRIX, the subject experienced injection site redness and swelling injection site. The adverse events of redness and swelling were reported as local injection site reactions. The subject was treated with antibiotics. The events resolved approximately 6 days later.
Resident tested positive for COVID on 01/06/2021.  Resident received monoclonal antibody treatment on 01/19/2021.
Shingles/ Shingles flare up; facial/ scalp lesions; rash; This case was reported by a other health professional via call center representative and described the occurrence of shingles in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) for prophylaxis.   Concurrent medical conditions included scalp pain and facial pain.   On 11th September 2019, the patient received Shingrix and Influenza vaccine Quadrivalent 2019-2020 season. On 12th September 2019, 1 days after receiving Shingrix and Influenza vaccine Quadrivalent 2019-2020 season, the patient experienced shingles, skin lesion and facial rash. The patient was treated with antivirals nos, antivirals nos, antivirals nos, antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the shingles and facial rash were not recovered/not resolved and the outcome of the skin lesion was unknown.   It was unknown if the reporter considered the shingles, skin lesion and facial rash to be related to Shingrix and Influenza vaccine Quadrivalent 2019-2020 season.  Additional case details were provided as follows: The patient complained of soreness in the face and scalp area prior to vaccination. A day after the vaccination with Shingrix and Quadravalant vaccine, the patient developed facial or scalp lesion and rash with a confirmed diagnosis of Shingles. Antiviral therapy was given to the patient but the he reported that, rash was again developed on the same area on his face. The patient consented to follow up.
Temperature and head/body aches began about 18 hours after vaccination. Temperature got to 104* and stayed there for approx 48 hours. Tried OTC Tylenol, Naproxen and Aspirin. Very tired for about 72 hours.
SKIPPED HEART BEATS; HEARTBURN; LACK OF APPETITE; IRRITABILITY; FLU LIKE SYMPTOMS; ACHY; ANXIETY; MALAISE; PAIN IN LEGS; FATIGUE; MUSCLE CRAMPS; This spontaneous report received from a patient concerned a 38 year old female. The patient's weight was 106 pounds, and height was 64 inches. The patient's concurrent conditions included anxiety but its worsen, reactive hypoglycemia, sulfa allergy, non alcoholic, and non smoker, and other pre-existing medical conditions included the patient did not have any drug abuse or illicit drug use. The patient was previously treated with Cefaclor.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced flu like symptoms. On 08-APR-2021, the subject experienced achy. On 08-APR-2021, the subject experienced anxiety. On 08-APR-2021, the subject experienced muscle cramps. On 08-APR-2021, the subject experienced malaise. On 08-APR-2021, the subject experienced pain in legs. On 08-APR-2021, the subject experienced fatigue. On 09-APR-2021, the subject experienced lack of appetite. On 09-APR-2021, the subject experienced irritability. On 10-APR-2021, the subject experienced heartburn. On 10-APR-2021, the subject experienced skipped heart beats. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pain in legs on 10-APR-2021, was recovering from lack of appetite, anxiety, and heartburn, and had not recovered from flu like symptoms, malaise, achy, irritability, muscle cramps, skipped heart beats, and fatigue. This report was non-serious.
Patient is a 78 y.o. male with PMH HTN, CKD, Prior CVA who presented from home on 7/21/2023 with generalized weakness due to COVID infection. He had a positive home test on 7/21, he subsequently was started on Paxlovid which he completed a total of 3 days. He remained stable on RA, not requiring Oxygen therapy or steroids. Hospitalization was further complicated by profound diarrhea and pt was tested and found positive for C-diff. Started him on PO Vancomycin x10 days, diarrhea slowly improving. PT/OT followed and recommended SNF.       COVID infection Acute Bronchitis - Presented with: frequent cough, weakness, and fevers;  (unable to get out of bed). Came to the hospital after recommendation from PCP - Symptom onset: 7/20/2023 - Positive COVID-19: 7/21/2023 at home kit, not tested on admit; positive family members as well   - Vaccination status: Vaccinated with Pfizer with last dose 11/2022 - CXR on admission showed non-acute  - Oxygen status: stable on RA  - Decadron: Does not qualify due to SpO2>94% on RA.  - Remdesivir: Does not qualify due to SpO2>94% on RA. - Completed 3 day course of Paxlovid - DVT prophylaxis:Lovenox - Serial COVID labs ordered: No - Case Management/Social Services consulted: Yes; PT/OT following with plan for SNF at DC - continue good pulmonary hygiene/IS    C-Diff  - pt reporting multiple days and episodes of watery diarrhea - tested positive for C-diff - started on PO Vancomycin x10 days     Hypertension - elevated  - home regimen includes Procardia, Coreg, Clonidine, losartan  - resume home regimen, with hold parameters     CKD Stage 3b - stable; 1.29  - Gentle iv fluids on admit - Avoid nephrotoxic meds as able    History of stroke with residual cognitive and balance deficits Secondary parkinsonism - One in 2017 and one  in 2021.  Has ambulatory dysfunction since then and top of that patient has parkinsonism. -Continue Sinemet, rivastigmine, aspirin and statin   Diabetes mellitus type 2 - A1c 6.4 -Diet controlled.  Previously on Tresiba, metformin which have discontinued. - start SSI, monitor and adjust as needed  - ADA diet at DC   History of PE Chronic right lower extremity DVT -Treated with anticoagulation in the past - Lovenox for vte proph while here Hemochromatosis - per history; Follows with Ohio State hematology - Phlebotomy in the past.  - monitor CBC daily    Anxiety/depression - Continue home dose Celexa and Wellbutrin   Vascular Dementia - Follows with Neurology - resume OP management    Generalized Weakness Reduced mobility, PTA - In setting of known Parkinson's, now exacerbated by Covid infection - At baseline he uses a walker and is able to go up stairs (bedroom on 2nd floor of house) -On day of admit, was unable to get out of bed by himself - PT/OT recommending SNF at DC
Began having pain on left side of rib cage on Friday, November 19 around 3PM.     It became worse on Saturday evening, November 20 at 10:30PM.   On Sunday evening, November 21 I went to the Emergency room about 6PM.     A CT scan revealed I had Bilateral pulmonary embolism (HCC).    I was prescribed ELOQUIS and sent home to follow up with a cardiologist.    I have an appointment on November 30 at 3PM.
Breakthrough COVID case: 06/02/2022- rash appeared primarily on left upper forearm and, eventually, on both arms and both legs, from shoulder to wrist and from hip to ankle. 06/04/2022- Husband tested positive for COVID at urgent care clinic. 06/05/2022- Sore throat, headache, achy feeling. 06/06/2022- Visited urgent care clinic, tested negative. 06/07/2022 - Sore throat, headache, achy feeling, congestion, and fever of 99.4. Tested positive on 2 home test kits. Telehealth visit with primary care office. Prescribed COVID antiviral medication but I was out of state and could not get it. 06/08/2022- Another telehealth visit with primary care office. Prescribed a different COVID antiviral medication, PAXLOVID. Fever 100.8. Started PAXLOVID that evening. 06/09/2022- Fever improved to 99.5. Follow up telehealth visit to primary care office. All symptoms began improving. 06/10/2022- All symptoms continued to improve. 06/11-06/12- All symptoms continued to improve. 06/13/2022- Completed PAXLOVID.
Patient developed angioedema 15 min after receiving vaccine, swelling located to the lips and lower jaw
pt recv vax JUL95 & devel complete lt facial paralysis;pt was seen by MD who stated that facial paralysis was probably Bell's Palsy;tx Medrol & instructed to perform facial massage;
No adverse event; Patient were potentially impacted with a compromised dose of the Moderna COVID-19 monovalent vaccine.; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient were potentially impacted with a compromised dose of the Moderna COVID-19 monovalent vaccine.) and NO ADVERSE EVENT (No adverse event) in an 11-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. AS1417B and AS1903B) for COVID-19 prophylaxis.     No Medical History information was reported.   On 22-Mar-2023, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2023, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Apr-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced WRONG PRODUCT ADMINISTERED (Patient were potentially impacted with a compromised dose of the Moderna COVID-19 monovalent vaccine.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient were potentially impacted with a compromised dose of the Moderna COVID-19 monovalent vaccine.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient were potentially impacted with a compromised dose of the Moderna COVID-19 monovalent vaccine.).    No concomitant medication was reported.  The patient had not reported any adverse reactions. No treatment medication was reported. This case is reported for patient 2 out of 2 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-737622 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-737622:Patient 2
severe flare of (known) trigeminal neuralgia, oral mucositis, fever, body aches, chills, and swelling/redness/warmth at side of vaccination
Patient reported that two days after injection she experienced intense pain and redness in her upper left arm. It went from her elbow up to her arm pit and into chest area. She took some Benadryl and slept, and says that symptoms resolved within two days. She also reports having body aches during that time. She did not seek any medical care and did not report symptoms until next visit in April.
8 weeks since first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (8 weeks since first dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (8 weeks since first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (8 weeks since first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information were provided. Treatment information was not provided.
Information has been received from a physician concerning a 49 year old female with thyroid papillary carcinoma, asthma and drug hypersensitivity to procaine and a history of renal cyst who on 25-JUL-2008 was vaccinated with RECOMBIVAX HB.  Concomitant therapy included levothyroxine Na, LEXAPRO, WELLBUTRIN, and ADVAIR DISKUS.  On 03-SEP-2008 the patient was vaccinated with a second dose of RECOMBIVAX HB (lot # 659670/0475X) and developed redness, pain, swelling and itching on her left arm at the injection site a few days after receiving her second dose of RECOMBIVAX HB.  Medical attention was sought.  The patient was diagnosed with a sterile abscess at the injection site.  No other information was available.  Additional information has been requested.
Fever to 103.5 followed few minutes later by loss of consciousness, limp body and shaking of lower extremities for few seconds.  Whole episode lasted about 1 minute.  Diagnosed as febrile seizure.
7 hours after: temperature spiked to 103 within the course of an hour.  8 hours after: chills so severe I considered seeking urgent care, wondering whether they were seizures.  12 hours after: felt some sort of mass move through my heart, wondered if it was a transient ischemic attack; but nothing followed. 7 days after: bridge of nose (only) turned red, almost burgundy, unusually/ strangely/ heavily flushed; woke up with unexplained headaches for 3 out of 4 days that week (and I never get headaches). 12 days after: nose flushing had faded; no more headaches; but routine exercise (even stairs) feels unusually/ markedly more difficult. 4 weeks later: gradually beginning to run/ jog again, slowly improving times/ getting back toward normal cardiopulmonary strength.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ANAPHYLAXIS, SUBSEQ ANAPHYLAXIS, SEQUELA
Left leg inflammation and redness, lower thigh to patellar area.  Swollen tender to touch, good joint movement.
I started itching all over at l0:00 PM on Friday, Jan. 22.  My feet and hands began tingling and turning numb.  I took Benadryl and was ok in 2 - 3 hours.  I never had any breathing problems.
Information has been received from a licensed visiting nurse concerning a 2 month old patient who was vaccinated with an oral first dose of Rotateq. Within the last two months, in approximately October 2006, the patient experienced one to three days of diarrhea. It was noted that the series at the time of the report would be continued unless the physician decided otherwise. At the time of the report the patient was recovering. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Swollen, warm , red sore 3 inches in diameter around injection site.  Progressed to larger size day 8.
Patient was given Bexsero in error. Reported to the office the next day complaining of upset stomach and painful/swollen deltoid.
Pt had a tdap in her left deltoid muscle on 7/15/08 at school.  She reported her typical injection pain.  On the 5th day after the immunzation, pt developed +redness, +itching, +warmth.  She presented to school on 7/22/08 for Mumps (dose 2), varicella (dose 2) and ppd.  Immunizations were deferred due to left shoulder pain.
2/1/22 pt tested positive for COVID and was hospitalized; prolonged mechanical ventilation; tracheostomy; PEG tube; dc'd to LTCF; 5/17/22 back to hospital Rehabilitation Unit; past 2 days with increasing SOB; admitted to hospital 6/5/22; BiPAP; ICU; Pulmonary Edema and possible pneumonia; Bumex started; required intubation; condition worsened; failed ventilation weaning; finally passed weaning and extubated; plans to place tracheostomy; pt labored on BiPAP; family transitioned pt to comfort care/hospice and she died in the hospital
This spontaneous report was received from a physician via a company representative and refers to a 62 year old female patient. There was no information regarding the patient's medical history, concomitant medications, drug reactions or allergies provided. On an unspecified date, 2 or three years before report's date, the patient was vaccinated with ZOSTAVAX, 0.65 ml subcutaneously for prophylaxis (lot number and expiration date were not provided). On an unknown date (reported as recently), the patient was seen in physician's office with shingles. The outcome of the event was reported as recovering/resolving. The causality assessment between the event and ZOSTAVAX was not provided. Additional information has been requested.
Days 2 & 3: extreme redness and swelling on injection site, fussiness. Day 5: tiredness, fussiness, lethargic, 105 fever, seizure.
eye checkup showed patient blind in right eye due to blood blockage in main retinal vein.
Suspected vaccination failure/had the shots and got shingles; shingles anyway; need to use walker now; Right leg,  now have nerve damage; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In October 2022, unknown after receiving Shingles vaccine, the patient experienced nerve damage. On an unknown date, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and unable to walk. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the nerve damage and unable to walk were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, nerve damage and unable to walk to be related to Shingles vaccine.     Additional Information: GSK receipt date: 7-Oct-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient had the shots and got shingles anyway in right leg and now had nerve damage in that leg.  The patient need to use a walker now.  The patient stated that no fun.  Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
High fever, chills, body aches and nausea. Bed rest and Tylenol for 36 hours. Still weak.
Ringing in both ears started shortly after injection, minor ringing has continued. Treatment included antibiotics from PCP to treat for possible ear infection. Saw immunologist about risk of second dose, held off on second dose for 4 months, no improvement or increase of severity.
About 5 days after initial vaccine I began a period that was the heaviest I had ever had.  After 10 days I contacted my Dr. who ordered blood work.  Did blood work on 4/5, by this time period had finally slowed to spotting.  Had 2nd vaccine on 4/6 and immediately started bleeding heavily again and about 4 days in had four or five clots the size of half dollars or larger.  Saw  Dr. on 4/14  and  ordered another blood test and was prescribed iron pills for anemia.  As of the date 4/20, I am still bleeding with no signs of stopping.
This spontaneous report as received from a pharmacy technician refers to 3 unspecified patients of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On an unknown date, the patients were vaccinated with improperly stored VARIVAX lot # M027344 with expiry date: 01-JUN-2018 (dosing details, anatomical location, route were unknown) for prophylaxis. It was reported that the vaccines were exposed to a temperature range of 15 F to 46F (18.3F) for a duration of 7 hours and 45 minutes. During previous temperature excursion vaccines were exposed to a temperature range of 6 F to 14 F (10.6F) for 1 hour and 15 minutes and 15F to 46F (19.2F) for 14 hours and 30 minutes. Data logger was involved. No adverse symptoms were reported. There were no product quality complaints (PQC) involved. This is second of the two reports from the same reporter.; Sender's Comments: US-009507513-1708USA009630:
Presents w/R arm swelling/soreness since GARDASIL injection on 9/11/18. Never occurred before. Denies F/C or other systemic sxs. Doing ice therapy and elevation. No meds/NSAIDs use.
Breakthrough case admission after 2 vaccines Moderna 10/1/21 Lot# 014F21A;  Moderna 10/29/21 Lot# 039f21a
pt in ER last noc pt stopped breathing for no apparent reason, & sz @ daycare;T107 @ ER;febrile sz;OM, pneumonia;turned blue & passed out;skin flushed;dry, cranky;rapid resp;lethargic, crying;nasal mucosa;
Having neck pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Having neck pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced NECK PAIN (Having neck pain). At the time of the report, NECK PAIN (Having neck pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was included took  acetaminophen for pain to help her sleep.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow up received including Event outcome was updated to recovered/resolved.
Tingling of fingertips Tingling turned into numbness Slight chest pains Upper back pain Sudden rise in blood pressure Myocardial Infarction (Heart Attack)
pt had a previous hospitalization for A Fib with RVR and COVID pneumonia; was dc'd to home; back to ED the following day with malaise, and body aches; family states unable to care for her; placed on steroids, O2 supplementation; suffered right pleural effusion, CHF, s/p thoracentesis x 2; generalized debilitation; poor prognosis; dc'd to Rehab where she later passed away; pt status changed to DNR; family refused PEG for pt
Second day: soreness at the site. Fatigue and nausea. Third, fourth and fifth day fatigue and head ache
NO ADVERSE EVENT-MD ORDERED & PATIENT RECEIVED DTaP. THIS VACCINE IS NOT RECOMMENDED FOR CHILDREN PAST 6 YEARS OF AGE
Presented to ED with complaints of Fever, chills, and myalgia. Symptoms transitioned into lethargy and weakness.  Treatments: Physical Therapy for strengthening, lab work, fever reducing medications!